SRX Global Inc. (SRXH)
What's happening with SRXH?
Powered by Yahoo ScoutSRX Global continues to expand its portfolio with significant developments in clinical-stage companies, including ARMR Sciences and CERo Therapeutics. Recent updates highlight positive trial results and strategic acquisitions aimed at enhancing shareholder value.
- Previous Close
1.5600 - Open
1.5600 - Bid 1.5000 x 50000
- Ask 1.5100 x 60000
- Day's Range
1.4900 - 1.5650 - 52 Week Range
0.9600 - 42.6000 - Volume
346,741 - Avg. Volume
4,129,881 - Market Cap (intraday)
30.601M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-132.3400 - Earnings Date (est.) --
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 22, 2026
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (5yr expected)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
--
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-60k
-
Diluted EPS (ttm)
-132.3400
Balance Sheet and Cash Flow
-
Total Cash (mrq)
48.19M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
--
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
